Format

Send to

Choose Destination
Int J Eat Disord. 2010 Nov 1;43(7):596-602. doi: 10.1002/eat.20754.

Cost-utility of treatment of bulimia nervosa.

Author information

1
Department of Psychiatry, Helsinki and Uusimaa Hospital District, Helsinki, Finland. veera.pohjolainen@fimnet.fi

Abstract

OBJECTIVE:

The costs of treating eating disorders are high. Our objective was to perform a cost-utility analysis of treatment of bulimia nervosa.

METHOD:

72 patients entering treatment of bulimia nervosa (ICD-10 diagnosis) completed the 15D health-related quality of life (HRQoL) questionnaire and the Eating Disorder Inventory (EDI) before and 6 months after the start of treatment. Quality-adjusted life years (QALYs) gained were calculated and cost-utility was assessed within the time horizon of 10 years.

RESULTS:

Baseline HRQoL was severely impaired in the patients. As a consequence of treatment, mean HRQoL improved clinically and statistically significantly. The cost per QALY gained varied from €1,455 to €16,481 (from €4,428 to €19,663 discounted at 5%) depending on the assumptions used in the analysis.

DISCUSSION:

HRQoL of bulimia nervosa patients is severely impaired, but treatment has a clear positive effect on HRQoL. The cost per QALY gained is comparable to many other treatments.

PMID:
19806609
DOI:
10.1002/eat.20754
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center